A detailed history of Brandywine Global Investment Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Brandywine Global Investment Management, LLC holds 1,265,734 shares of PFE stock, worth $35.4 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
1,265,734
Previous 1,842,172 31.29%
Holding current value
$35.4 Million
Previous $53 Million 33.77%
% of portfolio
0.26%
Previous 0.44%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$25.89 - $29.73 $14.9 Million - $17.1 Million
-576,438 Reduced 31.29%
1,265,734 $35.1 Million
Q4 2023

Feb 09, 2024

BUY
$26.13 - $33.94 $2.49 Million - $3.23 Million
95,220 Added 5.45%
1,842,172 $53 Million
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $1.96 Million - $2.29 Million
-60,929 Reduced 3.37%
1,746,952 $57.9 Million
Q2 2023

Aug 11, 2023

SELL
$36.12 - $41.79 $116 Million - $135 Million
-3,224,121 Reduced 64.07%
1,807,881 $66.3 Million
Q1 2023

May 12, 2023

BUY
$39.39 - $51.28 $642,332 - $836,222
16,307 Added 0.33%
5,032,002 $205 Million
Q4 2022

Feb 10, 2023

BUY
$41.75 - $54.5 $32.3 Million - $42.2 Million
774,656 Added 18.27%
5,015,695 $257 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $10.5 Million - $12.8 Million
-239,696 Reduced 5.35%
4,241,039 $186 Million
Q2 2022

Aug 11, 2022

BUY
$46.53 - $55.17 $150 Million - $177 Million
3,214,678 Added 253.91%
4,480,735 $235 Million
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $13.8 Million - $17.1 Million
300,889 Added 31.17%
1,266,057 $65.5 Million
Q4 2021

Feb 11, 2022

SELL
$41.32 - $61.25 $20.1 Million - $29.8 Million
-485,966 Reduced 33.49%
965,168 $57 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $24.2 Million - $31.1 Million
616,250 Added 73.81%
1,451,134 $62.4 Million
Q2 2021

Aug 13, 2021

SELL
$35.91 - $40.68 $417,417 - $472,864
-11,624 Reduced 1.37%
834,884 $32.7 Million
Q1 2021

May 13, 2021

SELL
$33.49 - $37.77 $146 Million - $165 Million
-4,361,095 Reduced 83.74%
846,508 $30.7 Million
Q4 2020

Feb 10, 2021

SELL
$33.47 - $42.56 $3.53 Million - $4.49 Million
-105,579 Reduced 1.99%
5,207,603 $192 Million
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $15.2 Million - $17.9 Million
-479,298 Reduced 8.27%
5,313,182 $195 Million
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $54.6 Million - $66.3 Million
1,813,895 Added 45.59%
5,792,480 $189 Million
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $13.7 Million - $19.6 Million
-508,490 Reduced 11.33%
3,978,585 $130 Million
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $37 Million - $41.9 Million
-1,122,655 Reduced 20.01%
4,487,075 $176 Million
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $77.8 Million - $101 Million
-2,394,178 Reduced 29.91%
5,609,730 $202 Million
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $11.9 Million - $13.3 Million
-320,655 Reduced 3.85%
8,003,908 $347 Million
Q1 2019

May 15, 2019

BUY
$37.5 - $41.2 $93.6 Million - $103 Million
2,495,388 Added 42.81%
8,324,563 $354 Million
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $32 Million - $36.5 Million
-831,807 Reduced 12.49%
5,829,175 $254 Million
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $15.3 Million - $18.5 Million
-442,968 Reduced 6.24%
6,660,982 $294 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $26.6 Million - $28.4 Million
-807,451 Reduced 10.21%
7,103,950 $258 Million
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $13.4 Million - $15.6 Million
420,426 Added 5.61%
7,911,401 $281 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $26.2 Million - $27.8 Million
786,795 Added 11.74%
7,490,975 $271 Million
Q3 2017

Nov 14, 2017

SELL
$31.0 - $34.15 $6.67 Million - $7.35 Million
-215,287 Reduced 3.11%
6,704,180 $239 Million
Q2 2017

Aug 14, 2017

BUY
N/A
6,919,467
6,919,467 $232 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Brandywine Global Investment Management, LLC Portfolio

Follow Brandywine Global Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Global Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Global Investment Management, LLC with notifications on news.